These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 27826805)

  • 21. Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting.
    Morgan D; Sylvester H; Lucas FL; Miesfeldt S
    Genet Med; 2010 Jan; 12(1):25-31. PubMed ID: 20027114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
    Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
    BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies.
    Kinney AY; Gammon A; Coxworth J; Simonsen SE; Arce-Laretta M
    Genet Med; 2010 Feb; 12(2):105-15. PubMed ID: 20061960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types.
    Wakefield CE; Kasparian NA; Meiser B; Homewood J; Kirk J; Tucker K
    Genet Test; 2007; 11(4):401-11. PubMed ID: 18294057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of National Comprehensive Cancer Network guideline-based Tool for Risk Assessment for breast and ovarian Cancer (N-TRAC): A patient-reported survey for genetic high-risk assessment for breast and ovarian cancers in women.
    Ozanne EM; Howe R; Mallinson D; Esserman L; Van't Veer LJ; Kaplan CP
    J Genet Couns; 2019 Jun; 28(3):507-515. PubMed ID: 30663827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.
    An J; Lu SE; McDougall J; Walters ST; Lin Y; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
    Ann Behav Med; 2023 Oct; 57(11):965-977. PubMed ID: 37658805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.
    Lynch HT; Snyder CL; Lynch JF; Riley BD; Rubinstein WS
    J Clin Oncol; 2003 Feb; 21(4):740-53. PubMed ID: 12586815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. All in the Family: Barriers and Motivators to the Use of Cancer Family History Questionnaires and the Impact on Attendance Rates.
    Armel SR; McCuaig J; Gojska N; Demsky R; Maganti M; Murphy J; Rosen B
    J Genet Couns; 2015 Oct; 24(5):822-32. PubMed ID: 25558824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and pilot testing of a training for bilingual community education professionals about hereditary breast and ovarian cancer among Latinas: ÁRBOLES Familiares.
    Vadaparampil ST; Moreno Botero L; Fuzzell L; Garcia J; Jandorf L; Hurtado-de-Mendoza A; Campos-Galvan C; Peshkin BN; Schwartz MD; Lopez K; Ricker C; Fiallos K; Quinn GP; Graves KD
    Transl Behav Med; 2022 Jan; 12(1):. PubMed ID: 34255089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.
    Joseph G; Kaplan C; Luce J; Lee R; Stewart S; Guerra C; Pasick R
    Public Health Genomics; 2012; 15(3-4):172-80. PubMed ID: 22488460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
    Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
    Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community-based organizations.
    Bowen A; Gómez-Trillos S; Curran G; Graves KD; Sheppard VB; Schwartz MD; Peshkin BN; Campos C; Garcés N; Dash C; Aburto L; Valencia-Rojas N; Hernández G; Villa A; Cupertino P; Carrera P; Hurtado-de-Mendoza A
    J Genet Couns; 2023 Oct; 32(5):965-981. PubMed ID: 37062905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis.
    Swanson CL; Kumar A; Maharaj JM; Kemppainen JL; Thomas BC; Weinhold MR; Slaby KM; Mara KC; Wick MJ; Bakkum-Gamez JN
    Gynecol Oncol; 2018 Apr; 149(1):121-126. PubMed ID: 29402500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.
    Mallen AR; Conley CC; Fuzzell L; Ketcher D; Augusto BM; McIntyre M; Barton LV; Townsend MK; Fridley BL; Tworoger SS; Wenham RM; Vadaparampil ST
    Support Care Cancer; 2021 May; 29(5):2663-2677. PubMed ID: 32975643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
    Head M; Cohn B; Wernli KJ; Palazzo L; Ehrlich K; Matson A; Knerr S
    Womens Health Issues; 2024; 34(3):268-275. PubMed ID: 38448251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk.
    Vogel TJ; Stoops K; Bennett RL; Miller M; Swisher EM
    Gynecol Oncol; 2012 Jun; 125(3):693-8. PubMed ID: 22446623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic counseling referral for ovarian cancer patients: a call to action.
    Garcia C; Harrison K; Ring KL; Sullivan MW; Rauh LA; Modesitt SC
    Fam Cancer; 2019 Jul; 18(3):303-309. PubMed ID: 30993488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing a Population-Based Breast Cancer Risk Assessment Program.
    Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A
    Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
    Brannon Traxler L; Martin ML; Kerber AS; Bellcross CA; Crane BE; Green V; Matthews R; Paris NM; Gabram SG
    Ann Surg Oncol; 2014 Oct; 21(10):3342-7. PubMed ID: 25047474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.